On Jan. 14, 2021, China National Medical Products Administration (NMPA) held a news briefing on Cosmetic Supervision and Administration Regulation (CSAR) implementation. [1] During the briefing, the following three officials answered several questions about CSAR implementation.
Liubin Qi, Deputy Director of the Department of Cosmetics Regulation of NMPA;
Qingbin Lin, Researcher of the Division of Supervision I; and
Yunfeng Li, Division Chief of the Division of Supervision II.
Source: NMPA Official Website
ChemLinked summarizes the key points as follows.